ambro morgans research

I copied this off a big article from Ambro Morgans, dated 23rd January, 2007.

Ventracor (VCR) Buy; Price Target: $1.25; Share Price: $1.10;
Market Cap: $287m.
VCR has announced the growing momentum in its European BRACE
study (Better Results and Cost Effectiveness) of the VentrAssist. There
are now six European centres implanting under the BRACE protocol.
Management has recently returned from meeting with analysts and
institutional investors in both the US and Europe

Cheers dma